Todd Yezefski

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer”.

Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00636-0

N/A

0.933DataRank · unranked

23 citations

Roman Gulati, Todd Yezefski, Heather H. Cheng, Elahe A. Mostaghel, Michael C. Haffner +17 more

Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study

JCO Precision Oncology(2024)10.1200/po.23.00634

N/A

0.406DataRank · unranked

14 citations

George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Colin C. Pritchard +13 more

PSMA expression and response to 177Lu-PSMA-617 (LuPSMA) in men with vs. without DNA damage repair (DDR) mutations.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5055

N/A

0.292DataRank · unranked

6 citations

George Mo, Michael C. Haffner, Colm Morrissey, Gavin Ha, Evan Y. Yu +9 more

Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.07.024

N/A

0.165DataRank · unranked

2 citations

Elizabeth Koehne, Jenna Voutsinas, Leonidas Nikolaos Diamantopoulos, Dimitrios Makrakis, Petros Grivas +19 more

Treatment response comparisons between ATM and BRCA2 germline carriers for mCRPC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.63

N/A

0.165DataRank · unranked

2 citations

Catherine H. Marshall, Rebeca Lozano, Petros Grivas, Celestia S. Higano, Tamara L. Lotan +11 more

Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency

European Urology Oncology(2025)10.1016/j.euo.2025.04.026

N/A

0.165DataRank · unranked

2 citations

Heather H. Cheng, Roman Gulati, Michael T. Schweizer, Aaron Lin, Todd Yezefski +7 more

Association of prior poly(ADP-ribose) polymerase (PARP) inhibitor therapy with response to 177Lu-PSMA-617 (LuPSMA) in men with DNA damage repair (DDR) mutations.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.4_suppl.128

N/A

0DataRank · unranked

0 citations

George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Colin C. Pritchard +11 more

Neoadjuvant pembrolizumab (pembro) and accelerated methotrexate, vinblastine, doxorubicin, cisplatin (aMVAC) in non-urothelial (non-UC) histologic subtype muscle invasive bladder cancer (MIBC): A phase 2 trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.769

N/A

0DataRank · unranked

2 citations

Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, Aaron Lin, Brianna Woo +15 more

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.10.002

N/A

0DataRank · unranked

19 citations

Sarah K. Holt, Ali Raza Khaki, Rishi Sekar, Adam J. Gadzinski, Yaw A. Nyame +17 more